Patients with this genetic variant are more likely to experience adverse drug reactions or failure of treatment.
Global Cancer Consortium
New Study: Robot-Assisted Hysterectomy Offers Similar (But Pricier) Results Compared to Laparoscopic Counterpart
According to the National Institutes of Health, one in three women in the U.S. will undergo a hysterectomy by the age of 60.
Diabetes, Oncology, Drug Delivery
MannKind is a biopharmaceutical company that actualizes therapeutics for the treatment of diabetes and cancer, and has also developed a novel inhalation-based drug delivery system that enables enhanced…
Oncology, Pain Management
Infinity Pharmaceuticals is a biopharmaceutical company that has developed a targeted drug development platform to actualize small molecule inhibitors against specific bioactive proteins that play critical roles in biological…
Oncology Drugs Experience Sales Slowdown In U.S.
Cancer drug sales are slowing down in the U.S., Reuters reported Monday.
Advanced Life Sciences Announces Two New Achievements
Advanced Life Sciences (OTC BB: ADLS) took two steps this week toward advancing its lead drug candidate, Restanza.
Cytori Therepeutics Featured in Wired Magazine
Wired magazine recently published a feature on Cytori Therapeutics, a regenerative medicine company based in San Diego that is using stem and regenerative stem cells derived from fat (adipose) tissue to repair breasts disfigured by mastectomies and lumpectomies.
GE Healthcare to Acquire Diagnostics Company Clarient
General Electric announced Friday that its healthcare unit will acquire molecular diagnostics company Clarient in a deal worth approximately $580 million.
